Health Catalyst, Inc. announced strong financial results for the first quarter ended March 31, 2025, with total revenue reaching $79.4 million. This figure surpassed the company's quarterly guidance, indicating robust performance.
Adjusted EBITDA for Q1 2025 also exceeded guidance, coming in at $6.3 million. The company reported adding 10 net new Platform Clients during the quarter, which is a positive indicator for achieving its annual target of 40 net new Platform Client additions in 2025.
Health Catalyst reiterated its full year 2025 guidance, projecting total revenue of approximately $335 million and Adjusted EBITDA of approximately $41 million. For the second quarter of 2025, the company expects total revenue of approximately $80.5 million and Adjusted EBITDA of approximately $8 million.
The content on BeyondSPX is for informational purposes only and should not be construed as financial or investment advice. We are not financial advisors. Consult with a qualified professional before making any investment decisions. Any actions you take based on information from this site are solely at your own risk.